NEKTAR THERAPEUTICSNEKTAR THERAPEUTICSNEKTAR THERAPEUTICS

NEKTAR THERAPEUTICS

No trades
See on Supercharts

Price target

84.270.000.00%
The 5 analysts offering 1 year price forecasts for NKTR have a max estimate of — and a min estimate of —.

Analyst rating

Based on 8 analysts giving stock ratings to NKTR in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


NKTR EPS for the last quarter is −3.55 MXN despite the estimation of −3.92 MXN. In the next quarter EPS is expected to reach −2.58 MXN. Track more of NEKTAR THERAPEUTICS financials and stay on top of what is up with the company.
In the next quarter NEKTAR THERAPEUTICS revenue is expected to reach ‪738.73 M‬ MXN. Check out NEKTAR THERAPEUTICS revenue and earnings and make informed decisions.
According to analysts, NKTR price target is 84.27 MXN with a max estimate of 141.79 MXN and a min estimate of 26.33 MXN. Check if this forecast comes true in a year, meanwhile watch NEKTAR THERAPEUTICS stock price chart and keep track of the current situation with NKTR news and stock market news.
We've gathered opinions of 8 analysts rating NKTR stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.